Nexalin Technology Announces Fourth Peer-Reviewed Publication in Alzheimer’s Disease: 15 mA DIFS™ Significantly Improves Sleep Quality in Patients with Mild Alzheimer’s Disease
27, 2026 (GLOBE NEWSWIRE) — Nexalin Technology, Inc.
Read source-backed brief